Answer
It targets cancers driven by particular BRAF mutations and should not be used for the listed cancers when the tumour has wild-type BRAF.
Sources for this answer
- Braftovi 75 mg hard capsule — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.